Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff3319a9f3d-trace').style.display = (document.getElementById('cakeErr67ff3319a9f3d-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ff3319a9f3d-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff3319a9f3d-code').style.display = (document.getElementById('cakeErr67ff3319a9f3d-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff3319a9f3d-context').style.display = (document.getElementById('cakeErr67ff3319a9f3d-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ff3319a9f3d-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ff3319a9f3d-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 27120,
		&#039;title&#039; =&gt; &#039;Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 27 January, 2015, http://timesofindia.indiatimes.com/business/india-business/Promote-Indian-drugs-US-health-groups-urge-Obama/articleshow/46024692.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4675167,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 27120,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Intellectual Property Rights,patents,IPRs,healthcare,healthcare in india,Public Health,Access to Health,Access to Healthcare,Access to Medicines,generic medicine,generic medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 27120,
	&#039;title&#039; =&gt; &#039;Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 27 January, 2015, http://timesofindia.indiatimes.com/business/india-business/Promote-Indian-drugs-US-health-groups-urge-Obama/articleshow/46024692.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4675167,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {},
		(int) 10 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 27120
$metaTitle = &#039;LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;
$metaKeywords = &#039;Intellectual Property Rights,patents,IPRs,healthcare,healthcare in india,Public Health,Access to Health,Access to Healthcare,Access to Medicines,generic medicine,generic medicines&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Promote Indian drugs, US health groups urge Obama -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines essential for health care around the world&quot;.</p><p align="justify">This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters.</p><p align="justify">There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.</p><p align="justify">&quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&quot; civil society organizations said in the letter.</p><p align="justify">In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &quot;priority watch list country&quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India's manufacturing policy.</p><p align="justify">Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &quot;Recent US policy stances have sought to topple parts of India's intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&quot;</p><p align="justify"><br />India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.</p><p align="justify">While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.</p><p align="justify">&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff3319a9f3d-trace').style.display = (document.getElementById('cakeErr67ff3319a9f3d-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ff3319a9f3d-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff3319a9f3d-code').style.display = (document.getElementById('cakeErr67ff3319a9f3d-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff3319a9f3d-context').style.display = (document.getElementById('cakeErr67ff3319a9f3d-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ff3319a9f3d-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ff3319a9f3d-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 27120,
		&#039;title&#039; =&gt; &#039;Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 27 January, 2015, http://timesofindia.indiatimes.com/business/india-business/Promote-Indian-drugs-US-health-groups-urge-Obama/articleshow/46024692.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4675167,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 27120,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Intellectual Property Rights,patents,IPRs,healthcare,healthcare in india,Public Health,Access to Health,Access to Healthcare,Access to Medicines,generic medicine,generic medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 27120,
	&#039;title&#039; =&gt; &#039;Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 27 January, 2015, http://timesofindia.indiatimes.com/business/india-business/Promote-Indian-drugs-US-health-groups-urge-Obama/articleshow/46024692.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4675167,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {},
		(int) 10 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 27120
$metaTitle = &#039;LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;
$metaKeywords = &#039;Intellectual Property Rights,patents,IPRs,healthcare,healthcare in india,Public Health,Access to Health,Access to Healthcare,Access to Medicines,generic medicine,generic medicines&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Promote Indian drugs, US health groups urge Obama -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines essential for health care around the world&quot;.</p><p align="justify">This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters.</p><p align="justify">There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.</p><p align="justify">&quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&quot; civil society organizations said in the letter.</p><p align="justify">In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &quot;priority watch list country&quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India's manufacturing policy.</p><p align="justify">Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &quot;Recent US policy stances have sought to topple parts of India's intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&quot;</p><p align="justify"><br />India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.</p><p align="justify">While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.</p><p align="justify">&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff3319a9f3d-trace').style.display = (document.getElementById('cakeErr67ff3319a9f3d-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ff3319a9f3d-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff3319a9f3d-code').style.display = (document.getElementById('cakeErr67ff3319a9f3d-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff3319a9f3d-context').style.display = (document.getElementById('cakeErr67ff3319a9f3d-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ff3319a9f3d-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ff3319a9f3d-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 27120,
		&#039;title&#039; =&gt; &#039;Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 27 January, 2015, http://timesofindia.indiatimes.com/business/india-business/Promote-Indian-drugs-US-health-groups-urge-Obama/articleshow/46024692.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4675167,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 27120,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Intellectual Property Rights,patents,IPRs,healthcare,healthcare in india,Public Health,Access to Health,Access to Healthcare,Access to Medicines,generic medicine,generic medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 27120,
	&#039;title&#039; =&gt; &#039;Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 27 January, 2015, http://timesofindia.indiatimes.com/business/india-business/Promote-Indian-drugs-US-health-groups-urge-Obama/articleshow/46024692.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4675167,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {},
		(int) 10 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 27120
$metaTitle = &#039;LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey&#039;
$metaKeywords = &#039;Intellectual Property Rights,patents,IPRs,healthcare,healthcare in india,Public Health,Access to Health,Access to Healthcare,Access to Medicines,generic medicine,generic medicines&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &amp;quot;high-quality, low-cost generic medicines essential for health care around the world&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday&#039;s joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders&#039; consultations on related policy matters.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&amp;quot; civil society organizations said in the letter.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &amp;quot;priority watch list country&amp;quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India&#039;s manufacturing policy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &amp;quot;Recent US policy stances have sought to topple parts of India&#039;s intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama&#039;s visit to India assume significance not only for the Indian pharma industry but for patients across the world.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Promote Indian drugs, US health groups urge Obama -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines essential for health care around the world&quot;.</p><p align="justify">This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters.</p><p align="justify">There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.</p><p align="justify">&quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&quot; civil society organizations said in the letter.</p><p align="justify">In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &quot;priority watch list country&quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India's manufacturing policy.</p><p align="justify">Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &quot;Recent US policy stances have sought to topple parts of India's intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&quot;</p><p align="justify"><br />India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.</p><p align="justify">While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.</p><p align="justify">&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 27120,
		'title' => 'Promote Indian drugs, US health groups urge Obama -Sushmi Dey',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines essential for health care around the world&quot;.
</p>
<p align="justify">
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters.
</p>
<p align="justify">
There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.
</p>
<p align="justify">
&quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&quot; civil society organizations said in the letter.
</p>
<p align="justify">
In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &quot;priority watch list country&quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India's manufacturing policy.
</p>
<p align="justify">
Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &quot;Recent US policy stances have sought to topple parts of India's intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&quot;
</p>
<p align="justify">
<br />
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
</p>
<p align="justify">
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.
</p>
<p align="justify">
&nbsp;
</p>',
		'credit_writer' => 'The Times of India, 27 January, 2015, http://timesofindia.indiatimes.com/business/india-business/Promote-Indian-drugs-US-health-groups-urge-Obama/articleshow/46024692.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4675167,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 27120,
	'metaTitle' => 'LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey',
	'metaKeywords' => 'Intellectual Property Rights,patents,IPRs,healthcare,healthcare in india,Public Health,Access to Health,Access to Healthcare,Access to Medicines,generic medicine,generic medicines',
	'metaDesc' => '
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines...',
	'disp' => '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines essential for health care around the world&quot;.</p><p align="justify">This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters.</p><p align="justify">There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.</p><p align="justify">&quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&quot; civil society organizations said in the letter.</p><p align="justify">In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &quot;priority watch list country&quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India's manufacturing policy.</p><p align="justify">Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &quot;Recent US policy stances have sought to topple parts of India's intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&quot;</p><p align="justify"><br />India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.</p><p align="justify">While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.</p><p align="justify">&nbsp;</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 27120,
	'title' => 'Promote Indian drugs, US health groups urge Obama -Sushmi Dey',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines essential for health care around the world&quot;.
</p>
<p align="justify">
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters.
</p>
<p align="justify">
There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.
</p>
<p align="justify">
&quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&quot; civil society organizations said in the letter.
</p>
<p align="justify">
In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &quot;priority watch list country&quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India's manufacturing policy.
</p>
<p align="justify">
Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &quot;Recent US policy stances have sought to topple parts of India's intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&quot;
</p>
<p align="justify">
<br />
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
</p>
<p align="justify">
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.
</p>
<p align="justify">
&nbsp;
</p>',
	'credit_writer' => 'The Times of India, 27 January, 2015, http://timesofindia.indiatimes.com/business/india-business/Promote-Indian-drugs-US-health-groups-urge-Obama/articleshow/46024692.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'promote-indian-drugs-us-health-groups-urge-obama-sushmi-dey-4675167',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4675167,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {},
		(int) 7 => object(Cake\ORM\Entity) {},
		(int) 8 => object(Cake\ORM\Entity) {},
		(int) 9 => object(Cake\ORM\Entity) {},
		(int) 10 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 27120
$metaTitle = 'LATEST NEWS UPDATES | Promote Indian drugs, US health groups urge Obama -Sushmi Dey'
$metaKeywords = 'Intellectual Property Rights,patents,IPRs,healthcare,healthcare in india,Public Health,Access to Health,Access to Healthcare,Access to Medicines,generic medicine,generic medicines'
$metaDesc = '
-The Times of India


NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines...'
$disp = '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing &quot;high-quality, low-cost generic medicines essential for health care around the world&quot;.</p><p align="justify">This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters.</p><p align="justify">There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India.</p><p align="justify">&quot;Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere,&quot; civil society organizations said in the letter.</p><p align="justify">In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a &quot;priority watch list country&quot;, highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India's manufacturing policy.</p><p align="justify">Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, &quot;Recent US policy stances have sought to topple parts of India's intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights.&quot;</p><p align="justify"><br />India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.</p><p align="justify">While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.</p><p align="justify">&nbsp;</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Promote Indian drugs, US health groups urge Obama -Sushmi Dey

-The Times of India NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing "high-quality, low-cost generic medicines essential for health care around the world". This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the ObamaModi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters. There are concerns that US is pressuring India to push for liberal policies in favour of pharma MNCs seeking patent protection for their products in India. "Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the US, in India, in Africa or elsewhere," civil society organizations said in the letter. In April, the US brought out the Special 301 report taking unilateral measure to pressure countries to accept IPR protection beyond WTO obligations. The report classified India as a "priority watch list country", highlighting concerns related to Indian patent law, grant of compulsory licence and inclusion of a statement relating to CL for green technologies in India's manufacturing policy. Adding Indian laws are compliant to the WTO TRIPS agreement, the civil society letter said, "Recent US policy stances have sought to topple parts of India's intellectual property regime that protect public health to advance interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights." India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world. While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.